Literature DB >> 27141940

Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Miaohua Mo1,2, Shan Wang1,2, Ying Zhou1,2, Hong Li3, Yaojiong Wu4.   

Abstract

Mesenchymal stem cells (MSC) are capable of differentiating into cells of multiple cell lineages and have potent paracrine effects. Due to their easy preparation and low immunogenicity, MSC have emerged as an extremely promising therapeutic agent in regenerative medicine for diverse diseases. However, MSC are heterogeneous with respect to phenotype and function in current isolation and cultivation regimes, which often lead to incomparable experimental results. In addition, there may be specific stem cell subpopulations with definite differentiation capacity toward certain lineages in addition to stem cells with multi-differentiation potential. Recent studies have identified several subsets of MSC which exhibit distinct features and biological activities, and enhanced therapeutic potentials for certain diseases. In this review, we give an overview of these subsets for their phenotypic, biological and functional properties.

Keywords:  CD146; Cell surface markers; Heterogeneity; PDGFR; Stromal cells

Mesh:

Substances:

Year:  2016        PMID: 27141940     DOI: 10.1007/s00018-016-2229-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  121 in total

1.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Authors:  Stan Gronthos; Andrew C W Zannettino; Shelley J Hay; Songtao Shi; Stephen E Graves; Angela Kortesidis; Paul J Simmons
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

2.  CNS stem cells express a new class of intermediate filament protein.

Authors:  U Lendahl; L B Zimmerman; R D McKay
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

Review 3.  Concise review: the surface markers and identity of human mesenchymal stem cells.

Authors:  Feng-Juan Lv; Rocky S Tuan; Kenneth M C Cheung; Victor Y L Leung
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

4.  Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury.

Authors:  Zhe Wang; Yu Wang; Zhiyong Wang; J Silvio Gutkind; Zhongliang Wang; Fu Wang; Jie Lu; Gang Niu; Gaojun Teng; Xiaoyuan Chen
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

5.  Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.

Authors:  Shin Iinuma; Eriko Aikawa; Katsuto Tamai; Ryo Fujita; Yasushi Kikuchi; Takenao Chino; Junichi Kikuta; John A McGrath; Jouni Uitto; Masaru Ishii; Hajime Iizuka; Yasufumi Kaneda
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

6.  Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.

Authors:  Hirotsugu Hamamoto; Joseph H Gorman; Liam P Ryan; Robin Hinmon; Timothy P Martens; Michael D Schuster; Theodore Plappert; Matti Kiupel; Martin G St John-Sutton; Silviu Itescu; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

7.  Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency.

Authors:  Stephen G Ball; Adrian Shuttleworth; Cay M Kielty
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

8.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.

Authors:  Satoru Morikawa; Yo Mabuchi; Yoshiaki Kubota; Yasuo Nagai; Kunimichi Niibe; Emi Hiratsu; Sadafumi Suzuki; Chikako Miyauchi-Hara; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Atsushi Miyawaki; Taneaki Nakagawa; Toshio Suda; Hideyuki Okano; Yumi Matsuzaki
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

9.  Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration.

Authors:  Richard J Cuthbert; Peter V Giannoudis; Xiao N Wang; Lindsay Nicholson; David Pawson; Anatole Lubenko; Hiang B Tan; Anne Dickinson; Dennis McGonagle; Elena Jones
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

10.  In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells.

Authors:  Hatixhe Latifi-Pupovci; Zyrafete Kuçi; Sibylle Wehner; Halvard Bönig; Ralf Lieberz; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  J Transl Med       Date:  2015-09-25       Impact factor: 5.531

View more
  40 in total

1.  Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property.

Authors:  Shan Wang; Miaohua Mo; Jinmei Wang; Sobia Sadia; Bihua Shi; Xiaobing Fu; Lin Yu; Edward E Tredget; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

2.  Remodeled CD146+CD271+ Bone Marrow Mesenchymal Stem Cells from Patients with Polycythemia Vera Exhibit Altered Hematopoietic Supportive Activity.

Authors:  Chao Chen; Mingying Zhang; Rong Li; Jiajia Yuan; Jinqiang Yan; Yuhui Zhang; Wen Xing; Jie Bai; Yuan Zhou
Journal:  Stem Cell Rev Rep       Date:  2022-08-26       Impact factor: 6.692

3.  Self-Assembled Nano-Peptide Hydrogels with Human Umbilical Cord Mesenchymal Stem Cell Spheroids Accelerate Diabetic Skin Wound Healing by Inhibiting Inflammation and Promoting Angiogenesis.

Authors:  Junshuai Xue; Nianfeng Sun; Yang Liu
Journal:  Int J Nanomedicine       Date:  2022-05-30

4.  A Single-Cell Raman Spectroscopy Analysis of Bone Marrow Mesenchymal Stem/Stromal Cells to Identify Inter-Individual Diversity.

Authors:  Tamara Kukolj; Jasmina Lazarević; Ana Borojević; Uroš Ralević; Dragana Vujić; Aleksandra Jauković; Nenad Lazarević; Diana Bugarski
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

5.  CD317-Positive Immune Stromal Cells in Human "Mesenchymal Stem Cell" Populations.

Authors:  Alasdair G Kay; James M Fox; James P Hewitson; Andrew P Stone; Sophie Robertson; Sally James; Xiao-Nong Wang; Elizabeth Kapasa; Xuebin B Yang; Paul G Genever
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

6.  Altered expression of circular RNAs in human placental chorionic plate-derived mesenchymal stem cells pretreated with hypoxia.

Authors:  Xunsha Sun; Yulin Jin; Qihua Liang; Jie Tang; Jinsong Chen; Qiuxia Yu; Fatao Li; Yan Li; Jieying Wu; Shaoqing Wu
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

7.  High-fat diet selectively decreases bone marrow lin- /CD117+ cell population in aging mice through increased ROS production.

Authors:  Yichao Xiao; Qingyi Zhu; Xuanyou Liu; Meng Jiang; Hong Hao; Hua Zhu; Peter J Cowan; Xiaoming He; Qiming Liu; Shenghua Zhou; Zhenguo Liu
Journal:  J Tissue Eng Regen Med       Date:  2020-05-12       Impact factor: 3.963

8.  CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis.

Authors:  Qiong Li; Huifang Hou; Meng Li; Xia Yu; Hongbo Zuo; Jianhui Gao; Min Zhang; Zongjin Li; Zhikun Guo
Journal:  Front Cell Dev Biol       Date:  2021-05-12

Review 9.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

Review 10.  Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering.

Authors:  Yu Seon Kim; Antonios G Mikos
Journal:  J Control Release       Date:  2020-12-31       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.